Liraglutide Enhances Autophagy and Promotes Pancreatic β Cell Proliferation to Ameliorate Type 2 Diabetes in High-Fat-Fed and Streptozotocin-Treated Mice.

about

Liraglutide Enhances Autophagy and Promotes Pancreatic β Cell Proliferation to Ameliorate Type 2 Diabetes in High-Fat-Fed and Streptozotocin-Treated Mice.

Item

http://www.wikidata.org/entity/Q55378347

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Liraglutide Enhances Autophagy ...... d Streptozotocin-Treated Mice.

@en

Liraglutide Enhances Autophagy ...... d Streptozotocin-Treated Mice.

@nl

type

Item

label

Liraglutide Enhances Autophagy ...... d Streptozotocin-Treated Mice.

@en

Liraglutide Enhances Autophagy ...... d Streptozotocin-Treated Mice.

@nl

prefLabel

Liraglutide Enhances Autophagy ...... d Streptozotocin-Treated Mice.

@en

Liraglutide Enhances Autophagy ...... d Streptozotocin-Treated Mice.

@nl

P1476

Liraglutide Enhances Autophagy ...... d Streptozotocin-Treated Mice.

@en

P2093

Hongwei Jiang

http://www.w3.org/2001/XMLSchema#string

Jiannan Wu

http://www.w3.org/2001/XMLSchema#string

Liping Li

http://www.w3.org/2001/XMLSchema#string

Menglin Fan

http://www.w3.org/2001/XMLSchema#string

Yingyu Zhang

http://www.w3.org/2001/XMLSchema#string

Yujin Ma

http://www.w3.org/2001/XMLSchema#string

P2860

A Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic β-Cells in Type 2 Diabetic Mice

Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice

Autophagy and metabolism

Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats

Is there a link between liraglutide and pancreatitis? A post hoc review of pooled and patient-level data from completed liraglutide type 2 diabetes clinical trials.

Depression and its measurement in verbal adolescents and adults with autism spectrum disorder.

Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.

Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells

Liraglutide protects pancreatic β-cells against free fatty acids in vitro and affects glucolipid metabolism in apolipoprotein E-/- mice by activating autophagy.

Immunohistochemical (Ki-67) study of endometrial maturation in mice after use of phosphodiesterase type 5 inhibitor.

P304

2310-2316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.906286

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29664069

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5917824

http://www.w3.org/2001/XMLSchema#string